Inventor · Tangxia, CN

Chaofeng Long

17Patents

2h-index

45Co-inventors

46Inventor score

Filing activity: Mar 16, 2015 → Jun 19, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US9938292B2	Quinoline derivatives as SMO inhibitors	Chemistry; Metallurgy	18	Active
US11535613B2	Crystal form and salt form of pyridoimidazole compound and preparation method therefor	Chemistry; Metallurgy	3	Active
US11136319B2	Anti-influenza virus pyrimidine derivative	Chemistry; Metallurgy	2	Active
US10278973B2	Hydroxyl purine compounds and use thereof	Chemistry; Metallurgy	2	Active
US10526320B2	Pyrrolidine derivatives as PPAR agonists	Chemistry; Metallurgy	2	Active
US10654808B2	Tyrosine kinase inhibitor and pharmaceutical composition comprising same	Chemistry; Metallurgy	1	Active
US11725009B2	Anti-influenza virus pyrimidine derivative	Chemistry; Metallurgy	1	Active
US10399981B2	Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseases	Chemistry; Metallurgy	1	Active
US11008292B2	FGFR4 inhibitor and preparation method and use thereof	Chemistry; Metallurgy	1	Active
US12252487B2	Dominant salt forms of pyrimidine derivatives, and crystal forms thereof	Chemistry; Metallurgy	0	Active
US10532053B2	Histone deacetylase inhibitor, and preparation method and use thereof	Chemistry; Metallurgy	0	Active
US10098885B2	Hydroxyl purine compounds and applications thereof	Chemistry; Metallurgy	0	Active
US10766862B2	Crystal form and salt form of and preparation method for tyrosine kinase inhibitor	Chemistry; Metallurgy	0	Active
USRE49128E1	Hydroxyl purine compounds and applications thereof	General	0	Active
US10618898B2	Hydroxyl purine compounds and use thereof	Chemistry; Metallurgy	0	Active
US11440903B2	Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof	Chemistry; Metallurgy	0	Active
US12319692B2	Anti-influenza virus pyrimidine derivatives	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.